Reliability of Conclusions from Early Analyses of Real-World Data for Newly Approved Drugs in Advanced Gastric Cancer in the United States
Lisa M Hess et al, 2020, Pragmatic and Observational Research CrossRef
Role of ARPC2 in Human Gastric Cancer Jun Zhang et al, 2017, Mediators of Inflammation CrossRef
Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype Laura Caggiari et al, 2017, International Journal of Molecular Sciences CrossRef
Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type Chen Xu et al, 2017, Oncotarget CrossRef
Conversion surgery after S-1 plus oxaliplatin combination chemotherapy for advanced gastric cancer with multiple liver metastases Tsutomu Namikawa et al, 2018, Clinical Journal of Gastroenterology CrossRef
Serum carbohydrate antigen 125 is a significant prognostic marker in patients with unresectable advanced or recurrent gastric cancer Tsutomu Namikawa et al, 2018, Surgery Today CrossRef
Role of general practice doctor in the treatment of Signet ring cell carcinoma Snežana Knežević et al, 2019, Praxis medica CrossRef
Docetaxel, oxaliplatin, 5FU, and trastuzumab as first-line therapy in patients with human epidermal receptor 2-positive advanced gastric or gastroesophageal junction cancer Giandomenico Roviello et al, 2018, Medicine CrossRef
Review of survival, safety, and clinical outcomes in HER2+ metastatic gastric cancer following the administration of trastuzumabPost-Trastuzumab Gastric Cancer Michelle D. Hackshaw et al, 2020, Cancer Treatment and Research Communications CrossRef
Clinical Implications of Molecular Heterogeneity of Gastric Cancer Petra Hudler et al, 2017, Gastric Cancer CrossRef
Correlation of trastuzumab-based treatment with clinical characteristics and prognosis in HER2-positive gastric and gastroesophageal junction cancer: A retrospective single center analysis A. Ilhan-Mutlu et al, 2018, Cancer Biology & Therapy CrossRef
Structural basis of a novel heterodimeric Fc for bispecific antibody production Hudie Wei et al, 2017, Oncotarget CrossRef